Headquarters United Kingdom Parent organization Imperial Innovations | Founded 1986 | |
 | ||
Stock price IVO (LON) 325.25 GBX +8.12 (+2.56%)10 Mar, 4:28 PM GMT - Disclaimer Subsidiaries Imperial Innovations | ||
Executive interview imperial innovations
Imperial Innovations is a UK technology commercialisation and investment company, based in London. Imperial Innovations is traded on the Alternative Investment Market of the London Stock Exchange.
Contents
- Executive interview imperial innovations
- History
- Business Activities
- Companies in Imperial Innovations Portfolio
- References
History
Imperial Innovations was founded in 1986 as a department of Imperial College London, later becoming a wholly owned subsidiary of the College.
In July 2006, shares in the company were admitted to trading on the Alternative Investment Market of the London Stock Exchange. Since 2006, Imperial Innovations has raised over £300 million to invest in early-stage technology businesses.
On 4 November 2010 Prime Minister David Cameron revealed in a speech given in East London that Imperial Innovations had agreed to advise on the creation of an accelerator space for spinout companies at the Queen Elizabeth Olympic Park as part of the new East London Tech City hub.
Business Activities
Imperial Innovations carries out technology commercialisation and investment activities. Technology commercialisation includes protecting intellectual property developed at Imperial College London and other partners, assisting with technology development and ultimately seeking to license technology to industry or forming a new company around the technology.
Investment is focused on making sustainable, long-term investments in early-stage companies in the sectors of: Therapeutics, Medtech & Diagnostics, Engineering & Materials and ICT & Digital.
Companies in Imperial Innovations' Portfolio
As at 31 July 2015, Imperial Innovations valued its portfolio of companies at £327.2 million. It had holdings in 98 companies. Of these, the top 20 most valuable companies accounted for a total net value of £292.3 million.
Notable companies in Imperial Innovations’ portfolio include Circassia Pharmaceuticals, a constituent of the FTSE 250 Index. Circassia is the most valuable company in Imperial Innovations’ portfolio.